Open Nav

John Kollins

Cofounder, President & CEO

Satsuma Pharmaceuticals, Inc.

John Kollins began his biopharmaceutical industry career in 1989 and has served in C-level and executive roles in multiple public and private biopharmaceutical companies, including Transcept Pharmaceuticals, OXiGENE, CovX, Renovis, Athena Neurosciences / Elan Pharmaceuticals, and Immunex. John earned an MBA from the University of Virginia's Darden School and an engineering degree from Duke University.

This speaker's sessions: